UN

Upendra Nath Thakur

Active Director Director DIN 09403169
DIN 09403169 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Upendra Nath Thakur

Data last updated:

Upendra Nath Thakur is a Director at Aro Pharma Private Limited (since 2021). The company operates in Healthcare. Aro Pharma Private Limited reported revenue of ₹5 Lakh (FY 2025).

DIN 09403169
Primary Designation Director
Industry Healthcare
First Appointment 17 Nov 2021
Oldest Company Age 4 yrs
Largest company Aro Pharma Private Limited · ₹5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aro Pharma Private Limited U85100BR2021PTC055180
Director17 Nov 20212021₹5 Lakh (FY 2025)Active

Board colleagues of Upendra Nath Thakur

NameDINCompanyDesignation
Savita Kumari09403170Aro Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aro Pharma Private Limited
Premium access

Shareholding and investment profile for Upendra Nath Thakur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Upendra Nath Thakur

Upendra Nath Thakur currently holds 1 directorship: Aro Pharma Private Limited (Director, since 17 Nov 2021, revenue ₹5 Lakh (FY 2025)).

Upendra Nath Thakur was first appointed on 17 Nov 2021 as Director at Aro Pharma Private Limited.

The current boards of Upendra Nath Thakur's companies include Savita Kumari (Aro Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available